Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms

Details for Australian Patent Application No. 2011223226 (hide)

Owner MetrioPharm AG

Inventors Breu, Josef; Brysch, Wolfgang; Kaiser, Astrid; Ludescher, Beate; Maass, Gerrit; Martin, Thomas; Milius, Wolfgang; Niedermaier, Michael

Agent Davies Collison Cave

Pub. Number AU-A-2011223226

PCT Pub. Number WO2011/107295

Priority 10002067.6 01.03.10 EP; 10075744.2 25.11.10 EP

Filing date 1 March 2011

Wipo publication date 9 September 2011

International Classifications

C07D 237/32 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

A61K 31/502 - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61P 37/02 Drugs for immunological or allergic disorders

Event Publications

25 October 2012 PCT application entered the National Phase

  PCT publication WO2011/107295 Priority application(s): WO2011/107295

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223236-Hot work tool and method for producing same

2011223222-Antibodies against phosphorylcholine in combination therapy with biologic agents